Concepedia

Hans Brevinge

HB

Statistics

Publications

23

Citations

1.5K

H-Index

19

Active since

1986

Affiliations

Sahlgrenska University Hospital(Current)

University of Gothenburg

Hans Brevinge is an author at Sahlgrenska University Hospital specializing in medicine, colorectal cancer, and oncology.

Publications per year

1986–2008

23

Publications

23

Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer

E. Lindholm, Hans Brevinge, E. Haglind · British journal of surgery · 2008 · 298 citations · Full text

Medicine, Oncology, Preventive Medicine +16

Results of Screening, Rescreening, and Follow-up in a Prospective Randomized Study for Detection of Colorectal Cancer by Fecal Occult Blood Testing: Results for 68,308 Subjects

J Kewenter, Hans Brevinge, Boel Engarås et al. · Scandinavian Journal of Gastroenterology · 1994 · 252 citations

Medicine, Oncology, Preventive Medicine +17

Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells.

Ke Zhang, Dan Baeckström, Hans Brevinge et al. · PubMed · 1996 · 90 citations

Life Sciences, Immunology, Oncology +16

Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study.

Peter Daneryd, Elisabeth Svanberg, Ulla Körner et al. · PubMed · 1998 · 86 citations

Medicine, Pharmacology, Pharmacotherapy +17

Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells

Ke Zhang, Dan Baeckström, Hans Brevinge et al. · Journal of Cellular Biochemistry · 1996 · 85 citations

Life Sciences, Immunology, Oncology +14

1–5 of 23